L. Nandini Moorthy, MD MS 2012

Size: px
Start display at page:

Download "L. Nandini Moorthy, MD MS 2012"

Transcription

1 L. Nandini Moorthy, MD MS 2012

2 L Nandini Moorthy, MD MS yo Ashkenazi male with proximal muscle pain and weakness, mild malar erythema and erythema over knees and dorsal aspect of PIPs Mild tenderness over bilateral thighs and arms Unable to walk for a long time because of thigh pain History of sore throat one week prior to admission (admit date 2/17/09) No history of major physical exertion No history of supplement intake Elevated muscle enzymes (CPK ~94,000, Aldolase~3400; LDH 267; AST1033; ALT 445) ESR WNL Mycoplasma, ASLO, EBV, Influenza A and B, Hep panel -ve ANA and Jo-1 ab negative

3 L Nandini Moorthy, MD MS 09 Inflammatory polymyositis, dermatomyositis, inclusion body myositis, myositis with malignancy, myositis with another collagen vascular disease Neurogenic Toxic or drug related Infections viruses (coxsackie, influenza,, HIV), bacteria (staph, strep), Lyme disease, toxoplasmosis Neoplasm Genetic/Metabolic Miscellaneous Benign hyper CK emia

4 Any post exertional fatigue or cramping Unusual exertion in a poorly conditioned person Fasting Alcohol Medications (cocaine etc) Prior infection Pattern of weakness (calf pain versus thigh pain) Travel or eosinophilia (most relevant for localized myositis) L Nandini Moorthy, MD MS 09

5 L Nandini Moorthy, MD MS 09 Generalized proximal muscle weakness after a prodrome Work up and treat for rhabdomyolysis Work up towards a diagnosis Most likely diagnosis is viral myositis (influenza, enterovirus, EBV, HIV, Hep B and C etc) Likely +ve History of sore throat +ve No history of increased physical exertion/heat exposure +ve The very elevated muscle enzymes +ve/ ve Erythema over knees and dorsum of PIPS Less likely Absent calf pain

6 TThe cutaneous manifestations could be subtle and this could still be the early manifestation. CCutaneous manifestations (Heliotrope rash, Gottron s papules, periungual erythema) usually follow muscle symptoms L Nandini Moorthy, MD MS 09

7 L Nandini Moorthy, MD MS 09 Malaise, easy fatigue, muscle fatigue, fever & rash Insidious symmetric progressive proximal muscle weakness & pain Acute onset-1/3 >/=2 mo or longer prior to diagnosis Constitutional: Fever 38-40C, easily fatigued, anorexia, malaise, wt loss Milestone regression Could our patient have early-onset JDM? If the enzymes do not decrease, would consider steroids; would do an MRI and consider EMG and /biopsy

8 JDM

9 L Nandini Moorthy, MD MS 09 MSKS: symmetric proximal- weakness of LE limb girdle; anterior neck flexors/back & abdo Inability to hold head upright/maintain a sitting posture/stop walking/unable to dress/climb stairs/gowers Pelvic girdle- stairs, Trendelenburg- weak hip adductors Severe (10%) distal musculature unable to move pharyngeal, hypopharyngeal, palatal, esophageal hypomotility- difficulty swallowing, dysphonia, palatal speech, nasal regurgitation- threat of aspiration DTRs usually nl

10 Clinical features L Nandini Moorthy, MD MS 09 Photosensitivity Sun exposures- onset /exacerbation Oral ulcers - pain on swallowing Vasculitic- eye corners, axillae, pressure points, stretch marks Dystrophic calcifications-40% within 6 months of onset Early flexion contractures - muscle inflammation Persistent arthritis with myositis- THINK MCTD!

11

12

13

14

15

16

17 Leukocytosis, anemia -rare unless GI bleed High CRP, ESR Microscopic hematuria IgA, IgG, IgE CPK, AST, Aldolase, LDH, ALT ANA ~10-85% MSA & MAA MRI T1-fibrosis, fat infiltration, atrophy T2-fat suppressed-edema/inflammation EMG Muscle biopsy L Nandini Moorthy, MD MS 09

18 Skeletal muscle perifascicular myopathy non-inflammatory capillaropathy disruption, degeneration, regeneration lymphocytic infiltrate -perimysium, perivascular L Nandini Moorthy, MD MS 09

19 L Nandini Moorthy, MD MS 09 Proximal muscle weakness Classic rash Elevated serum muscle enzymes Electromyographic changes Imaging Histopathology

20 Likely Elevated muscle enzymes Proximal muscle weakness Erythema over knees and PIPs (not classic Gottrens) Cutaneous signs are yet to appear? Less likely Muscle enzymes decreasing without any intervention Patient so well appearing Patient s weakness is not marked However the last two points are not really convincing!!!! L Nandini Moorthy, MD MS 2009

21 L Nandini Moorthy, MD MS 09 MRI of thigh (2/22/09): Showed patchy signal abnormalities involving bilateral thigh muscles most prominent in the adductor longus muscle most c/w myositis Cannot rule out Juvenile Dermatomyositis Although the muscle enzymes came down with hydration and time, they still remained elevated. Cannot rule out metabolic causes (in some cases can present in teens) Question: Post-infectious myositis versus JDM versus metabolic process? Answer: Follow the course

22 L Nandini Moorthy, MD MS 09 2/24/09: CPK 3412; AST 186; ALT 255 2/26/09: CPK 1502; Aldolase 40; AST 114; Ammonia 125 (27-102) Muscle enzymes still elevated Patient not doing GYM or other physical activities Questions remain: Post-viral myopathy versus Metabolic myopathy versus JDM (JDM lower on the list since enzymes are decreasing without any intervention) Could do EMG and /or Biopsy I decided to wait since the muscle enzymes were coming down, patient was feeling better and I wanted to consider another etiology

23 L Nandini Moorthy, MD MS 09 MSAs 40% of DM and PM patients Anti trna synthetase (Jo 1 in PM patients) antisynthetase syndrome myositis, interstitial lung disease, arthritis, Raynaud s phenomenon and hand skin lesions (mechanic s hand). Anti Mi 2 Acute onset, good prognosis; specific for DM Anti SRP Acute polymyositis with cardiac involvement, poor prognosis and poor response to therapy. MAA 20 50% of sera, encountered in connective tissue diseases PM/Scl nucleolar (overlap with Scleroderma) Anti Ku (overlap with other CTD) SnRNP (Small nuclear ribonuclear proteins) (overlap with other CTD) RoRNP (cytoplasmic ribonuclear proteins) (overlap with other CTD) All came back negative in our patient

24 L Nandini Moorthy, MD MS 09 Heterogeneous group of disorders Inability of skeletal muscle to produce or maintain adequate levels of energy (ATP Clinical features generally include: Fixed, progressive muscle weakness Premature fatigue Episodic aches, cramps and pains (Is this the first episode?) Occasionally extensive rhabdomyolysis with myoglobinuria Divided into: muscle glycogenoses disorders of lipid metabolism mitochondrial secondary myopathies (thyroid etc)

25 L Nandini Moorthy, MD MS 09 Many patients are asymptomatic Generally develop problems only when their level of activity or state of nutrition force their muscles to rely on the defective pathway; Episodes of weakness may be induced by fasting, unusual exercise intensity, intercurrent infection, alcohol consumption, general anesthesia or some medications In addition to proximal weakness, they may have elevated CK levels Myopathic changes on electromyography (EMG) and muscle Histology.

26 L Nandini Moorthy, MD MS 09 Neuro appointment at RWJMS Patient seen at the Neuromuscular center at CHOP Around that time(3/13/09), his muscle enzymes came down to normal (CPK 95; Aldolase 5.6; AST 21; ALT 27) (Ammonia 100) So the final opinion is viral myositis The slightly elevated recent Ammonia was it a false positive (I am always skeptical about outside labs)/ indicative of muscle fiber regeneration?

27 L Nandini Moorthy, MD MS 09 What if he has another episode? Would obtain EMG and a biopsy (expect myopathic changes) and send him to Neurology We minimized invasive testing (EMG and biopsy) We got an MRI no literature available on MRI findings in generalized viral myositis. Makes this case reportable!!!! Follow up is key!!!!

Inflammatory Myopathies 4 th year MBBS. Marwan Adwan MBChB, MSc, MRCPI, MRCP(rheum) Consultant Rheumatologist

Inflammatory Myopathies 4 th year MBBS. Marwan Adwan MBChB, MSc, MRCPI, MRCP(rheum) Consultant Rheumatologist Inflammatory Myopathies 4 th year MBBS Marwan Adwan MBChB, MSc, MRCPI, MRCP(rheum) Consultant Rheumatologist Case A 64 woman presents with erythematous itchy rash over back of hands & forehead. For 1 month

More information

POLYMYOSITIS (PM) DERMATOMYOSITIS (DM) Body myositis Eosinophilic myositis Giant cell myositis Focal / localised myositis Myopathies caused by

POLYMYOSITIS (PM) DERMATOMYOSITIS (DM) Body myositis Eosinophilic myositis Giant cell myositis Focal / localised myositis Myopathies caused by POLYMYOSITIS (PM) DERMATOMYOSITIS (DM) Body myositis Eosinophilic myositis Giant cell myositis Focal / localised myositis Myopathies caused by infections, drugs, toxins Definition Epidemiology Pathogenesis

More information

Autoantibodies in the Idiopathic Inflammatory Myopathies

Autoantibodies in the Idiopathic Inflammatory Myopathies Autoantibodies in the Idiopathic Inflammatory Myopathies Steven R. Ytterberg, M.D. Division of Rheumatology Mayo Clinic Rochester, MN The Myositis Association Annual Conference St. Louis, MO Sept. 25,

More information

2/23/18. Disclosures. Rheumatic Diseases of Childhood. Making Room for Rheumatology. I have nothing to disclose. James J.

2/23/18. Disclosures. Rheumatic Diseases of Childhood. Making Room for Rheumatology. I have nothing to disclose. James J. Making Room for Rheumatology James J. Nocton, MD Disclosures I have nothing to disclose Rheumatic Diseases of Childhood Juvenile Idiopathic Arthritis (JIA) Systemic Lupus Erythematosus (SLE) Juvenile Dermatomyositis

More information

What your autoantibodies tell us about your disease. Mark Gourley, MD

What your autoantibodies tell us about your disease. Mark Gourley, MD What your autoantibodies tell us about your disease Mark Gourley, MD The Importance of the Immune System Defends us against foreign invaders Self (cancer) and Nonself (virus, bacteria, etc.) But, if the

More information

Idiopathic inflammatory muscle diseases. Dr. Paul Etau Ekwom MBChB, MMED Kenyatta National Hospital, Nairobi-Kenya

Idiopathic inflammatory muscle diseases. Dr. Paul Etau Ekwom MBChB, MMED Kenyatta National Hospital, Nairobi-Kenya Idiopathic inflammatory muscle diseases. Dr. Paul Etau Ekwom MBChB, MMED Kenyatta National Hospital, Nairobi-Kenya I.W, 28 YRS, FEMALE SHOP STEWARD Referred to KNH on 16/06/09 from Thika Nursing Home Weakness

More information

The many faces of myositis. Marianne de Visser Academic Medical Centre Dept of Neurology Amsterdam The Netherlands

The many faces of myositis. Marianne de Visser Academic Medical Centre Dept of Neurology Amsterdam The Netherlands The many faces of myositis Marianne de Visser Academic Medical Centre Dept of Neurology Amsterdam The Netherlands Outline of the presentation Classification Diagnosis Therapy Prognosis Diagnostic criteria

More information

Case 1: History of J.H. Outside Evaluation. Outside Labs. Question #1

Case 1: History of J.H. Outside Evaluation. Outside Labs. Question #1 Case 1: History of J.H. 64 yo man seen at UCSF 6-256 25-07. 9 months ago onset progressive weakness of arms and legs, with muscle atrophy in arms. 4 months ago red scaly rash on face, back of hands and

More information

Objectives. Non-Traumatic Muscle Pathologies. Abnormal Muscle Signal Intensity. Inflammatory Myositis. Polymyostis / Dermatomyositis.

Objectives. Non-Traumatic Muscle Pathologies. Abnormal Muscle Signal Intensity. Inflammatory Myositis. Polymyostis / Dermatomyositis. Non-Traumatic Muscle Pathologies Ali Naraghi Division of Musculoskeletal Radiology Joint Department of Medical Imaging University of Toronto Objectives Define the range of non-traumatic pathologies affecting

More information

Budsakorn Darawankul, MD. Maharat Nakhon Ratchasima Hospital

Budsakorn Darawankul, MD. Maharat Nakhon Ratchasima Hospital Budsakorn Darawankul, MD. Maharat Nakhon Ratchasima Hospital Outline What is ANA? How to detect ANA? Clinical application Common autoantibody in ANA diseases Outline What is ANA? How to detect ANA? Clinical

More information

Myositis and Your Lungs

Myositis and Your Lungs Myositis and Your Lungs 2013 TMA Annual Patient Meeting Louisville, Kentucky Chester V. Oddis, MD University of Pittsburgh Director, Myositis Center Myositis Heterogeneous group of autoimmune syndromes

More information

Clinical Laboratory. 14:42:00 SSA-52 (Ro52) (ENA) Antibody, IgG 1 AU/mL [0-40] Oct-18

Clinical Laboratory. 14:42:00 SSA-52 (Ro52) (ENA) Antibody, IgG 1 AU/mL [0-40] Oct-18 Clinical Laboratory Procedure Result Units Ref Interval Accession Collected Received Rheumatoid Factor

More information

Muscle Pathology Surgical Pathology Unknown Conference. November, 2008 Philip Boyer, M.D., Ph.D.

Muscle Pathology Surgical Pathology Unknown Conference. November, 2008 Philip Boyer, M.D., Ph.D. Muscle Pathology Surgical Pathology Unknown Conference November, 2008 Philip Boyer, M.D., Ph.D. Etiologic Approach to Differential Diagnosis Symptoms / Signs / Imaging / Biopsy / CSF Analysis Normal Abnormal

More information

Disorders of Muscle. Disorders of Muscle. Muscle Groups Involved in Myopathy. Needle Examination of EMG. History. Muscle Biopsy

Disorders of Muscle. Disorders of Muscle. Muscle Groups Involved in Myopathy. Needle Examination of EMG. History. Muscle Biopsy Disorders of Muscle Disorders of Muscle Zakia Bell, M.D. Associate Professor of Neurology and Physical Medicine & Rehabilitation Virginia Commonwealth University Cardinal symptom of diseases of the muscle

More information

Diseases of Muscle and Neuromuscular Junction

Diseases of Muscle and Neuromuscular Junction Diseases of Muscle and Neuromuscular Junction Diseases of Muscle and Neuromuscular Junction Neuromuscular Junction Muscle Myastenia Gravis Eaton-Lambert Syndrome Toxic Infllammatory Denervation Atrophy

More information

MYOSITIS. A physician s guide to the

MYOSITIS. A physician s guide to the MYOSITIS A physician s guide to the TABLE OF CONTENTS Myositis basics... 1 contents... 3 Causes... 7... 11 Affected populations... 15 Diagnosis... 17... 25... 31 PHYSICIAN S GUIDE TO MYOSITIS matory

More information

Rheumatology E-learning. University of Szeged Department of Rheumatology and Immunology

Rheumatology E-learning. University of Szeged Department of Rheumatology and Immunology Rheumatology E-learning University of Szeged Department of Rheumatology and Immunology Introduction Idiopathic inflammatory myopathies (IIM) are a group of systemic diseases characterized by an immune

More information

IDIOPATHIC INFLAMMATORY MYOPATHIES AND RELATED DISORDERS. Franclo Henning Division of Neurology Tygerberg Hospital

IDIOPATHIC INFLAMMATORY MYOPATHIES AND RELATED DISORDERS. Franclo Henning Division of Neurology Tygerberg Hospital IDIOPATHIC INFLAMMATORY MYOPATHIES AND RELATED DISORDERS Franclo Henning Division of Neurology Tygerberg Hospital Classification systems Clinical (Bohan and Peter) Clinico-pathological (Dalakas & others)

More information

Jeopardy. What s the rash? $100 $100 $100 $100 $100 $200 $200 $200 $200 $200 $300 $300 $300 $300 $300 $400 $400 $400 $400 $400

Jeopardy. What s the rash? $100 $100 $100 $100 $100 $200 $200 $200 $200 $200 $300 $300 $300 $300 $300 $400 $400 $400 $400 $400 Jeopardy Antibodies & more antibodies Aching joints What s the rash? Potpourri Image Challenge $100 $100 $100 $100 $100 $200 $200 $200 $200 $200 $300 $300 $300 $300 $300 $400 $400 $400 $400 $400 $500 $500

More information

PedsCases Podcast Scripts

PedsCases Podcast Scripts Pedss Podcast Scripts This is a text version of a podcast from Pedscases.com on Juvenile Dermatomyositis. These podcasts are designed to give medical students an overview of key topics in pediatrics. The

More information

Test Name Results Units Bio. Ref. Interval

Test Name Results Units Bio. Ref. Interval LL - LL-ROHINI (NATIONAL REFERENCE 135091593 Age 25 Years Gender Male 30/8/2017 91600AM 30/8/2017 93946AM 31/8/2017 84826AM Ref By Final COLLAGEN DISEASES ANTIBODY ANEL ANTI NUCLEAR ANTIBODY / FACTOR (ANA/ANF),

More information

IMACS FORM 07b: MYOSITIS DISEASE ACTIVITY ASSESSMENT TOOL, Version

IMACS FORM 07b: MYOSITIS DISEASE ACTIVITY ASSESSMENT TOOL, Version IMACS FORM 07b: MYOSITIS ASSESSMENT TOOL, Version 2 2005 Subject s IMACS number: ASSESSOR: Date Assessed: Assessment number: The clinical features recorded are based upon the previous 4 weeks and the judgment

More information

Arthritis Superspeciality Center, Hubli, Karnataka and 2 Department of Rheumatology, SDM Medical College, Dharwad, Karnataka, India.

Arthritis Superspeciality Center, Hubli, Karnataka and 2 Department of Rheumatology, SDM Medical College, Dharwad, Karnataka, India. JOURNAL OF CASE REPORTS 2015;5(1):147-151 A Rare Case of Juvenile Dermatomyositis Vikram Haridas 1,2, Kiran Haridas 1 1,2 Arthritis Superspeciality Center, Hubli, Karnataka and 2 Department of Rheumatology,

More information

Acute Emergencies in Rheumatology

Acute Emergencies in Rheumatology Acute Emergencies in Rheumatology Clare Higgens Northwick Park hospital and St George s Hospital London Acute Rheumatological Emergencies The Acute Hot joint Inflammatory back pain.. Systemic lupus erythematosus(sle)

More information

Clinical Laboratory. 14:41:00 Complement Component 3 50 mg/dl Oct-18

Clinical Laboratory. 14:41:00 Complement Component 3 50 mg/dl Oct-18 Clinical Laboratory Procedure Result Units Ref Interval Accession Collected Received Thyroid Peroxidase (TPO) Antibody 5.0 IU/mL [0.0-9.0] 18-289-900139 16-Oct-18 Complement Component 3 50 mg/dl 18-289-900139

More information

DR.JANANI RAVI DR.GNANABALAN S UNIT DR.MEHTA CHILDREN HOSPITAL

DR.JANANI RAVI DR.GNANABALAN S UNIT DR.MEHTA CHILDREN HOSPITAL DR.JANANI RAVI DR.GNANABALAN S UNIT DR.MEHTA CHILDREN HOSPITAL 1 ½ year old girl c/o *Prolonged fever 20 days *Puffiness of face and legs 20 days *Rash in the lower limbs 20 days Child was suspected to

More information

Rheumatology 101 A Pediatrician s Guide

Rheumatology 101 A Pediatrician s Guide Rheumatology 101 A Pediatrician s Guide Pediatric Staff and Alumni Day 2016 Dawn M. Wahezi, Yonit Sterba, Tamar Rubinstein Disclosures None Pick a Group Group 1 A child with a limp Group 2 ANA To test

More information

High Impact Rheumatology

High Impact Rheumatology High Impact Rheumatology Systemic Lupus Erythematosus Bernard Rubin, DO MPH Case 1: History A 45-year-old woman presents with severe dyspnea and cough. She was in excellent health until 4 weeks ago when

More information

Clinical Laboratory. [None

Clinical Laboratory. [None Clinical Laboratory Procedure Result Units Ref Interval Accession Collected Received Double-Stranded DNA (dsdna) Ab IgG ELISA Detected * [None 18-289-900151 Detected] Double-Stranded DNA (dsdna) Ab IgG

More information

Autoantibodies in Idiopathic Inflammatory Myopathies. Vidya Limaye Rheumatology Department Royal Adelaide Hospital

Autoantibodies in Idiopathic Inflammatory Myopathies. Vidya Limaye Rheumatology Department Royal Adelaide Hospital Autoantibodies in Idiopathic Inflammatory Myopathies Vidya Limaye Rheumatology Department Royal Adelaide Hospital Idiopathic Inflammatory Myopathies (IIM) Heterogeneous group of systemic autoimmune syndromes

More information

Undifferentiated Connective Tissue Disease and Overlap Syndromes. Mark S. Box, MD

Undifferentiated Connective Tissue Disease and Overlap Syndromes. Mark S. Box, MD Undifferentiated Connective Tissue Disease and Overlap Syndromes Mark S. Box, MD Overlap Syndromes As many as 25% of patients with rheumatic diseases with systemic symptoms cannot be definitely diagnosed

More information

This month, we are very pleased to introduce some new tests for Scleroderma as well as some test changes to our existing scleroderma tests/panels.

This month, we are very pleased to introduce some new tests for Scleroderma as well as some test changes to our existing scleroderma tests/panels. February 20, 2017 Client Letter Test Update February 2017 Dear Colleague: This month, we are very pleased to introduce some new tests for Scleroderma as well as some test changes to our existing scleroderma

More information

Test Name Results Units Bio. Ref. Interval

Test Name Results Units Bio. Ref. Interval 135091660 Age 44 Years Gender Male 29/8/2017 120000AM 29/8/2017 100219AM 29/8/2017 105510AM Ref By Final EXTRACTABLENUCLEAR ANTIGENS (ENA), QUANTITATIVE ROFILE CENTROMERE ANTIBODY, SERUM 20-30 Weak ositive

More information

HUNGARIAN MYOSITIS COHORT

HUNGARIAN MYOSITIS COHORT CLINICAL ADVANCES OF ANTI- TIF1Γ AUTOANTIBODY IN A HUNGARIAN MYOSITIS COHORT Melinda Nagy-Vincze 1, Zoltán Griger 1, Levente Bodoki 1, Zsuzsa Szankai 1, Zoe E. Betteridge 2, Katalin Dankó 1 1 University

More information

Myositis 101. Steven R. Ytterberg, M.D. Division of Rheumatology Mayo Clinic, Rochester, MN

Myositis 101. Steven R. Ytterberg, M.D. Division of Rheumatology Mayo Clinic, Rochester, MN Myositis 101 Steven R. Ytterberg, M.D. Rheumatology Mayo Clinic, Rochester, MN Myositis Association Annual Conference Louisville, KY Sept. 6 & 7, 2018 Disclosures Consulting: Dynavax Pfizer Off-label use:

More information

Autoantibodies andprognosis. Jiří Vencovský Institute of Rheumatology, Prague, Czech Republic

Autoantibodies andprognosis. Jiří Vencovský Institute of Rheumatology, Prague, Czech Republic Autoantibodies andprognosis Jiří Vencovský Institute of Rheumatology, Prague, Czech Republic HeterogeneityofIIMs Diagnosis Polymyositis Dermatomyositis IBM Necrotising myopathy Paraneoplastic Amyopathic

More information

APPROACH TO PATIENTS WITH POLYARTHRALGIA

APPROACH TO PATIENTS WITH POLYARTHRALGIA APPROACH TO PATIENTS WITH POLYARTHRALGIA Scott Vogelgesang, MD Division of Immunology University of Iowa No conflicts of interest DEFINITIONS Arthralgia joint pain with no evidence of inflammation Arthritis

More information

SCLERODERMA OVERLAP SYNDROME: A CASE REPORT Diwakar K. Singh 1, Nataraju H. V 2

SCLERODERMA OVERLAP SYNDROME: A CASE REPORT Diwakar K. Singh 1, Nataraju H. V 2 SCLERODERMA OVERLAP SYNDROME: A Diwakar K. Singh 1, Nataraju H. V 2 HOW TO CITE THIS ARTICLE: Diwakar K. Singh, Nataraju H. V. Scleroderma Overlap Syndrome: A Case Report. Journal of Evolution of Medical

More information

JUVENILE DERMATOMYOSITIS

JUVENILE DERMATOMYOSITIS JUVENILE DERMATOMYOSITIS - how to diagnose, how to treat? Miloš Nikolić, MD, PhD Professor and Chairman Department of Dermatology, Division of Pediatric Dermatology University of Belgrade, School of Medicine,

More information

EDX in Myopathies Limitations. EDX in Myopathies Utility Causes of Myopathy. Myopathy: Issues for Electromyographers

EDX in Myopathies Limitations. EDX in Myopathies Utility Causes of Myopathy. Myopathy: Issues for Electromyographers Electrodiagnostic Assessment of Myopathy Myopathy: Issues for Electromyographers Often perceived as challenging Ian Grant Division of Neurology QEII Health Sciences Centre Halifax NS CNSF EMG Course June

More information

A48-year-old Hispanic woman

A48-year-old Hispanic woman Jamie Goodall, MS4, and Richard P. Usatine, MD University of Texas Health Science Center at San Antonio Skin rash and muscle weakness The patient s facial rash was spreading and she was having difficulty

More information

Idiopathic inflammatory myopathies excluding inclusion body myositis

Idiopathic inflammatory myopathies excluding inclusion body myositis Idiopathic inflammatory myopathies excluding inclusion body myositis Marianne de Visser, Dept. of Neurology, Academic Medical Centre, Amsterdam, The Netherlands The idiopathic inflammatory myopathies (IIMs),

More information

Tools to Aid in the Accurate Diagnosis of. Connective Tissue Disease

Tools to Aid in the Accurate Diagnosis of. Connective Tissue Disease Connective Tissue Disease Tools to Aid in the Accurate Diagnosis of Connective Tissue Disease Connective Tissue Disease High quality assays and novel tests Inova offers a complete array of assay methods,

More information

Muscular Dystrophies. Pinki Munot Consultant Paediatric Neurologist Great Ormond Street Hospital Practical Neurology Study days April 2018

Muscular Dystrophies. Pinki Munot Consultant Paediatric Neurologist Great Ormond Street Hospital Practical Neurology Study days April 2018 Muscular Dystrophies Pinki Munot Consultant Paediatric Neurologist Great Ormond Street Hospital Practical Neurology Study days April 2018 Definition and classification Clinical guide to recognize muscular

More information

MANAGING THE PATIENT WITH POSITIVE ANA

MANAGING THE PATIENT WITH POSITIVE ANA MANAGING THE PATIENT WITH POSITIVE ANA Rafael F. Rivas-Chacon, M.D. Disclosures Grant/Research support for: Pfizer Study JIA A3921104 Tofacitinib not related to this presentation 1 Positive Antinuclear

More information

Disclosures. Clinical Approach: Evaluating CTD-ILD for the pulmonologist. ILD in CTD. connective tissue disease or collagen vascular disease

Disclosures. Clinical Approach: Evaluating CTD-ILD for the pulmonologist. ILD in CTD. connective tissue disease or collagen vascular disease Disclosures Clinical Approach: Evaluating CTD-ILD for the pulmonologist Industry relationships: Actelion, atyr Pharma, Boehringer-Ingelheim, Genentech- Roche, Gilead Aryeh Fischer, MD Associate Professor

More information

Juvenile dermatomyositis in a 4-year-old Kenyan girl

Juvenile dermatomyositis in a 4-year-old Kenyan girl CASE REPORT Juvenile dermatomyositis in a 4-year-old Kenyan girl Marlous L. Grijsen 1,2, Deborah Mchaile 3, Inge Geut 4,5, Raimos Olomi 3, Maitseo Nwako 2, Luis Requena 6, William P. Howlett 5, Daudi R.

More information

Essential Rheumatology. Dr Ellen Bruce Consultant Rheumatologist CMFT

Essential Rheumatology. Dr Ellen Bruce Consultant Rheumatologist CMFT Essential Rheumatology Dr Ellen Bruce Consultant Rheumatologist CMFT Saving the best for last! Apparently people recall best the first and last thing they re told. Far too difficult to include everything.

More information

Autoantibodies panel ANA

Autoantibodies panel ANA Autoantibodies panel ANA Anti-nuclear antibodies, ANA screening General: Anti-nuclear antibodies (ANA) contain all kinds of autoantibodies against nuclear antigens. Their targets are cell components in

More information

1 DOS CME Course 2011

1 DOS CME Course 2011 Statin Myopathy February 23, 2011 Jinny Tavee, MD Associate Professor Neurological Institute Cleveland Clinic Foundation 1 Case 1 50 y/o woman with hyperlipidemia presents with one year history of deep

More information

Acquired Generalized Lipodystrophy. K30 Case Presentation Alice Chang Hoftman, M.D. Pediatric Rheumatology November 18, 2008

Acquired Generalized Lipodystrophy. K30 Case Presentation Alice Chang Hoftman, M.D. Pediatric Rheumatology November 18, 2008 Acquired Generalized Lipodystrophy K30 Case Presentation Alice Chang Hoftman, M.D. Pediatric Rheumatology November 18, 2008 Case presentation 2 yo girl admitted 12/31/07 to CHOC FUO x 1 week nodules along

More information

Muscular System. Disorders & Conditions

Muscular System. Disorders & Conditions Muscular System Disorders & Conditions Fibromyalgia Fibromyalgia is a disorder characterized by widespread musculoskeletal pain accompanied by fatigue, sleep, memory and mood issues. Often is described

More information

Overview of Diagnostic Autoantibodies in Inflammatory Myopathy

Overview of Diagnostic Autoantibodies in Inflammatory Myopathy Overview of Diagnostic Autoantibodies in Inflammatory Myopathy Minoru Satoh, M.D., Ph.D. Research Associate Professor of Medicine Division of Rheumatology and Clinical Immunology University of Florida

More information

Learn the steps to identify pediatric muscle weakness and signs of neuromuscular disease.

Learn the steps to identify pediatric muscle weakness and signs of neuromuscular disease. Learn the steps to identify pediatric muscle weakness and signs of neuromuscular disease. Listen Observe Evaluate Test Refer Guide for primary care providers includes: Surveillance Aid: Assessing Weakness

More information

RHEUMATOLOGY OVERVIEW. Carmelita J. Colbert, MD Assistant Professor of Medicine Division of Rheumatology Loyola University Medical Center

RHEUMATOLOGY OVERVIEW. Carmelita J. Colbert, MD Assistant Professor of Medicine Division of Rheumatology Loyola University Medical Center RHEUMATOLOGY OVERVIEW Carmelita J. Colbert, MD Assistant Professor of Medicine Division of Rheumatology Loyola University Medical Center What is Rheumatology? Medical science devoted to the rheumatic diseases

More information

Objectives. Joint Pain. Case 1. Rheumatology for the Primary MD (Not just your grandmother s disease) 12/4/2010

Objectives. Joint Pain. Case 1. Rheumatology for the Primary MD (Not just your grandmother s disease) 12/4/2010 Objectives Rheumatology for the Primary MD (Not just your grandmother s disease) Identify when it is appropriate to refer for rheumatologic evaluation Autoimmune/ Inflammatory v. noninflammatory disease

More information

4/16/2018. Demystifying weakness: how to approach refractory myositis. Objectives. Disclosures. Off-label uses for medications will be discussed

4/16/2018. Demystifying weakness: how to approach refractory myositis. Objectives. Disclosures. Off-label uses for medications will be discussed Demystifying weakness: how to approach refractory myositis Jemima Albayda, MD Assistant Professor Johns Hopkins Myositis center Disclosures Off-label uses for medications will be discussed Objectives To

More information

What are Autoantibodies and how do they work in Myositis?

What are Autoantibodies and how do they work in Myositis? What are Autoantibodies and how do they work in Myositis? Neil McHugh, University of Bath and Royal National Hospital for Rheumatic Diseases Orlando September 2015 Royal National Hospital for Rheumatic

More information

Types of osteoarthritis

Types of osteoarthritis ARTHRITIS Osteoarthritis is a degenerative joint disease is the most common joint disorder. It is a frequent part of aging and is an important cause of physical disability in persons older than 65 years

More information

Assessment of limping child (beware the child who does not weight bear at all):

Assessment of limping child (beware the child who does not weight bear at all): Department of Paediatrics Clinical Guideline Acutely Limping Child and Septic Arthritis Assessment of limping child (beware the child who does not weight bear at all): History Careful history of any significant

More information

Johns Hopkins Medicine - eform A

Johns Hopkins Medicine - eform A Johns Hopkins Medicine - eform A Use the section headings to write the eform A, inserting the appropriate material in each. If a section is not applicable, leave heading in and insert N/A. When submitting

More information

BSD Self Assessment Workshop 7 th July 2013 CASE 27 RAC6123

BSD Self Assessment Workshop 7 th July 2013 CASE 27 RAC6123 BSD Self Assessment Workshop 7 th July 2013 CASE 27 RAC6123 M55. 4/7 tender lesions on knee, legs and arms. Also iritis/ weight loss/headache, synovitis.?vasculitis. Sarcoidosis. Biopsy from left elbow

More information

Genetic diagnosis of limb girdle muscular dystrophy type 2A, A Case Report

Genetic diagnosis of limb girdle muscular dystrophy type 2A, A Case Report Genetic diagnosis of limb girdle muscular dystrophy type 2A, A Case Report Roshanak Jazayeri, MD, PhD Assistant Professor of Medical Genetics Faculty of Medicine, Alborz University of Medical Sciences

More information

*Pari Basharat ABSTRACT OVERVIEW OF IDIOPATHIC INFLAMMATORY MYOPATHIES

*Pari Basharat ABSTRACT OVERVIEW OF IDIOPATHIC INFLAMMATORY MYOPATHIES IDIOPATHIC INFLAMMATORY MYOPATHIES: ASSOCIATION WITH OVERLAP MYOSITIS AND SYNDROMES: CLASSIFICATION, CLINICAL CHARACTERISTICS, AND ASSOCIATED AUTOANTIBODIES *Pari Basharat University of Western Ontario,

More information

Myosites du sujet âgé

Myosites du sujet âgé Myosites du sujet âgé Olivier Benveniste Département de Médecine Interne Centre de Référence Maladies Neuro-Musculaires Equipe Muscle Inflammatoire U974 Groupe Hospitalier Pitié-Salpêtrière Myositis classification

More information

Department of Paediatrics Clinical Guideline. Guideline for the child with possible arthritis (joint swelling/pain, loss of function)

Department of Paediatrics Clinical Guideline. Guideline for the child with possible arthritis (joint swelling/pain, loss of function) Department of Paediatrics Clinical Guideline Guideline for the child with possible arthritis (joint swelling/pain, loss of function) Definition: Juvenile Idiopathic Arthritis (JIA) is defined as arthritis

More information

Test Name Results Units Bio. Ref. Interval

Test Name Results Units Bio. Ref. Interval 135091662 Age 45 Years Gender Male 29/8/2017 120000AM 29/8/2017 100215AM 29/8/2017 110825AM Ref By Final RHEUMATOID AUTOIMMUNE COMREHENSIVE ANEL ANTI NUCLEAR ANTIBODY / FACTOR (ANA/ANF), SERUM ----- 20-60

More information

Significance of antibody testing in idiopathic inflammatory myopathies

Significance of antibody testing in idiopathic inflammatory myopathies 2/0/20 Significance of antibody testing in idiopathic inflammatory myopathies Jiří Vencovský Institute of Rheumatology, Prague Diagnosis Polymyositis Juvenile DM (JPM) Paraneoplastic Myositis in overlap

More information

Discovery, Understanding, and Progress in Myositis

Discovery, Understanding, and Progress in Myositis Discovery, Understanding, and Progress in Myositis Steven Ytterberg, M.D. TMA Annual Patient Conference New Orleans, LA Sept. 2, 2016 Disclosures Financial: Dynavax Corp. Pfizer Mallinckrodt American Board

More information

Fat, ballooning, plasma cells and a +ANA. Yikes! USCAP 2016 Evening Specialty Conference Cynthia Guy

Fat, ballooning, plasma cells and a +ANA. Yikes! USCAP 2016 Evening Specialty Conference Cynthia Guy Fat, ballooning, plasma cells and a +ANA. Yikes! USCAP 2016 Evening Specialty Conference Cynthia Guy Goals Share an interesting case Important because it highlights a common problem that we re likely to

More information

Clinical Study A Clinical Analysis of Risk Factors for Interstitial Lung Disease in Patients with Idiopathic Inflammatory Myopathy

Clinical Study A Clinical Analysis of Risk Factors for Interstitial Lung Disease in Patients with Idiopathic Inflammatory Myopathy Clinical and Developmental Immunology Volume 2013, Article ID 648570, 4 pages http://dx.doi.org/10.1155/2013/648570 Clinical Study A Clinical Analysis of Risk Factors for Interstitial Lung Disease in Patients

More information

Disclosures. Rheumatological Approaches to Differential Diagnosis, Physical Examination, and Interpretation of Studies. None

Disclosures. Rheumatological Approaches to Differential Diagnosis, Physical Examination, and Interpretation of Studies. None Rheumatological Approaches to Differential Diagnosis, Physical Examination, and Interpretation of Studies Sarah Goglin MD Assistant Professor of Medicine Division of Rheumatology Disclosures None 1 [footer

More information

Is it Autoimmune or NOT! Presented to AONP! October 2015!

Is it Autoimmune or NOT! Presented to AONP! October 2015! Is it Autoimmune or NOT! Presented to AONP! October 2015! Four main jobs of immune system Detects Contains and eliminates Self regulates Protects Innate Immune System! Epithelial cells, phagocytic cells

More information

Department of Paediatrics Clinical Guideline

Department of Paediatrics Clinical Guideline Department of Paediatrics Clinical Guideline The child and young person with possible arthritis (joint swelling and/or pain, loss of function for >4 weeks) Definition: Juvenile Idiopathic Arthritis (JIA)

More information

9/13/2015. Nothing to disclose

9/13/2015. Nothing to disclose Jared Bozeman Kathleen Luskin MD Bipin Thapa MD Medical College of Wisconsin Milwaukee, Wisconsin Nothing to disclose 24 Year old previously healthy woman presenting from OSH Fatigue Weakness Neck swelling

More information

Pulmonary And Central Nervous System Involvement In Juvenile Dermatomyositis: Vasculopathy And/Or Steroids As Causative Agents - A Case Report

Pulmonary And Central Nervous System Involvement In Juvenile Dermatomyositis: Vasculopathy And/Or Steroids As Causative Agents - A Case Report ISPUB.COM The Internet Journal of Radiology Volume 4 Number 1 Pulmonary And Central Nervous System Involvement In Juvenile Dermatomyositis: Vasculopathy And/Or Steroids As Causative Agents - A Case Report

More information

9/11/11. Temporal Arteritis. Background. Background. Richard E. Castillo, OD, DO NORTHEASTERN STATE UNIVERSITY Director, Ophthalmic Surgery Service

9/11/11. Temporal Arteritis. Background. Background. Richard E. Castillo, OD, DO NORTHEASTERN STATE UNIVERSITY Director, Ophthalmic Surgery Service Temporal Arteritis Richard E. Castillo, OD, DO NORTHEASTERN STATE UNIVERSITY Director, Ophthalmic Surgery Service 1 Background Giant Cell Arteritis Temporal Arteritis Cranial Arteritis Granulomatous Arteritis

More information

Evolving Uses of IVIG in myositis

Evolving Uses of IVIG in myositis Evolving Uses of IVIG in myositis Rossitza I. Chichkova, MD, MS Associate Professor Depts of Neurology and Internal Medicine University of South Florida, Tampa, FL Immune Function In Normal State: Protects

More information

Chronic focal polymyositis in the adult

Chronic focal polymyositis in the adult Journal of Neurology, Neurosurgery, and Psychiatry, 1981, 44, 419-425 Chronic focal polymyositis in the adult N E BHARUCHA AND J A MORGAN-HUGHES From the Institute of Neurology, Queen Square, London S

More information

Insights into the DX of Pediatric SLE

Insights into the DX of Pediatric SLE Insights into the DX of Pediatric SLE Dr. John H. Yost Pediatric Rheumatology Children s Hospital at Dartmouth Assistant Professor of Medicine Geisel School of Medicine at Dartmouth john.h.yost@hitchcock.org

More information

AUTOIMMUNE DISORDERS IN THE ACUTE SETTING

AUTOIMMUNE DISORDERS IN THE ACUTE SETTING AUTOIMMUNE DISORDERS IN THE ACUTE SETTING Diagnosis and Treatment Goals Aimee Borazanci, MD BNI Neuroimmunology Objectives Give an update on the causes for admission, clinical features, and outcomes of

More information

Case Report Paget s Disease of the Breast in a Patient with Amyopathic Dermatomyositis

Case Report Paget s Disease of the Breast in a Patient with Amyopathic Dermatomyositis Volume 2012, Article ID 515691, 4 pages doi:10.1155/2012/515691 Case Report Paget s Disease of the Breast in a Patient with Amyopathic Dermatomyositis Sirin Yasar, 1 Gunay Gurleyik, 2 Yesim Sabuncuoglu,

More information

Pediatric Rheumatology: A Case-based Approach to the Basics. Hilary M. Haftel, MD, MHPE University of Michigan Department of Pediatrics

Pediatric Rheumatology: A Case-based Approach to the Basics. Hilary M. Haftel, MD, MHPE University of Michigan Department of Pediatrics Pediatric Rheumatology: A Case-based Approach to the Basics Hilary M. Haftel, MD, MHPE University of Michigan Department of Pediatrics Disclosures I have no relevant financial relationships with the manufacturer(s)

More information

X-Plain Muscles Reference Summary

X-Plain Muscles Reference Summary X-Plain Reference Summary Introduction are very important elements of the human body. They account for about half of a person s weight. Understanding how muscles work and how they can be injured is necessary

More information

Novel Classification of Idiopathic Inflammatory Myopathies Based on Overlap Syndrome Features and Autoantibodies

Novel Classification of Idiopathic Inflammatory Myopathies Based on Overlap Syndrome Features and Autoantibodies Novel Classification of Idiopathic Inflammatory Myopathies Based on Overlap Syndrome Features and Autoantibodies Analysis of 100 French Canadian Patients Yves Troyanov, MD, Ira N. Targoff, MD, Jean-Luc

More information

Mary Derlacki, FNP. No financial relationships to disclose. Office Rheumatology for the Nurse Practitioner. Rheumatoid Arthritis

Mary Derlacki, FNP. No financial relationships to disclose. Office Rheumatology for the Nurse Practitioner. Rheumatoid Arthritis Office Rheumatology for the Nurse Practitioner Mary Derlacki, FNP Drs. Cassell and Boren Eugene, OR 541-687-0816 mderlacki@comcast.net No financial relationships to disclose Rheumatoid Arthritis 1% of

More information

Chronic Hepatitis C. Risk Factors

Chronic Hepatitis C. Risk Factors Chronic Hepatitis C The hepatitis C virus is one of the most important causes of chronic liver disease in the United States. Almost 4 million Americans or 1.8 percent of the U.S. population have an antibody

More information

MYOSITIS 101. Your guide to understanding myositis

MYOSITIS 101. Your guide to understanding myositis MYOSITIS 101 Your guide to understanding myositis Patients who are informed, who seek out other patients, and who develop helpful ways of communicating with their doctors have better outcomes. Because

More information

The Elevated CK ROBERT HAWKINS, M.D.

The Elevated CK ROBERT HAWKINS, M.D. The Elevated CK ROBERT HAWKINS, M.D. What is the difference between CK and CPK One has a P in it. One has kinase in it, the other has phosphokinase in it. There is no true difference. A kinase is, by definition,

More information

Environmental Influence in Autoimmune Diseases. Mark Gourley, MD

Environmental Influence in Autoimmune Diseases. Mark Gourley, MD Environmental Influence in Autoimmune Diseases Mark Gourley, MD Newsweek January, 2003 Current Knowledge of Environment and Myositis Environment Genes Autoimmunity What Is an Environmental Exposure?

More information

EBV and Infectious Mononucleosis. Infectious Disease Definitions. Infectious Diseases

EBV and Infectious Mononucleosis. Infectious Disease Definitions. Infectious Diseases Infectious Disease Definitions Infection when a microorganism invades a host and multiplies enough to disrupt normal function by causing signs and symptoms Pathogencity ability of an organism to cause

More information

Physiotherapy in Juvenile Dermatomyositis

Physiotherapy in Juvenile Dermatomyositis Journal of Research and Practice on the Musculoskeletal System JOURNAL OF RESEARCH AND PRACTICE Review Article Physiotherapy in Juvenile Dermatomyositis Theodora Polychronopoulou Physiotherapist, Athens,

More information

4/11/2017. Cardiomyopathy. John Steuter, MD Bryan Heart. Disclosures. No Conflicts. Cardiomyopathy. WHO Classification

4/11/2017. Cardiomyopathy. John Steuter, MD Bryan Heart. Disclosures. No Conflicts. Cardiomyopathy. WHO Classification Cardiomyopathy John Steuter, MD Bryan Heart Disclosures No Conflicts Cardiomyopathy WHO Classification Anatomy & physiology of the LV 1. Dilated Enlarged Systolic dysfunction 2. Hypertrophic Thickened

More information

EXERTIONAL RHABDOMYOLYSIS. Jeffrey m mjaanes md, facsm

EXERTIONAL RHABDOMYOLYSIS. Jeffrey m mjaanes md, facsm EXERTIONAL RHABDOMYOLYSIS Jeffrey m mjaanes md, facsm LEARNING OBJECTIVES By the end of this presentation, the learner should be able to: 1. Describe the pathophysiology, potential contributing factors

More information

DOWNLOAD OR READ : MYOPATHIES AND MUSCLE DISEASES HANDBOOK OF CLINICAL NEUROLOGY PDF EBOOK EPUB MOBI

DOWNLOAD OR READ : MYOPATHIES AND MUSCLE DISEASES HANDBOOK OF CLINICAL NEUROLOGY PDF EBOOK EPUB MOBI DOWNLOAD OR READ : MYOPATHIES AND MUSCLE DISEASES HANDBOOK OF CLINICAL NEUROLOGY PDF EBOOK EPUB MOBI Page 1 Page 2 myopathies and muscle diseases handbook of clinical neurology myopathies and muscle diseases

More information

CHAPTER 1. Alcoholic Liver Disease

CHAPTER 1. Alcoholic Liver Disease CHAPTER 1 Alcoholic Liver Disease Major Lesions of Alcoholic Liver Disease Alcoholic fatty liver - >90% of binge and chronic drinkers Alcoholic hepatitis precursor of cirrhosis Alcoholic cirrhosis end

More information

THE TIP OF THE ICEBERG SAMER BOLIS, DO PGY-3 LEHIGH VALLEY HEALTH NETWORK, ALLENTOWN PA

THE TIP OF THE ICEBERG SAMER BOLIS, DO PGY-3 LEHIGH VALLEY HEALTH NETWORK, ALLENTOWN PA THE TIP OF THE ICEBERG SAMER BOLIS, DO PGY-3 LEHIGH VALLEY HEALTH NETWORK, ALLENTOWN PA Case The patient is a 48 year-old female, who recently returned from a trip to Puerto Rico. She presents to the ED

More information

Etiology: Pathogenesis Clinical manifestation Investigation Treatment Prognosis

Etiology: Pathogenesis Clinical manifestation Investigation Treatment Prognosis Etiology: Pathogenesis Clinical manifestation Investigation Treatment Prognosis JIA is the most common rheumatic disease in childhood and a major cause of chronic disability. Etiology: Unknown, but may

More information

Case conference. Welcome Dr. Lawrence Tierney

Case conference. Welcome Dr. Lawrence Tierney Case conference Welcome Dr. Lawrence Tierney Case: 18 year-old male CC) hamatomesis, Fever and cough HPI) 1 st admission One month ago, he admitted to our hospital because of hematemesis. He had weight

More information

Residual Functional Capacity Questionnaire SYSTEMIC LUPUS ERYTHEMATOSUS

Residual Functional Capacity Questionnaire SYSTEMIC LUPUS ERYTHEMATOSUS Residual Functional Capacity Questionnaire SYSTEMIC LUPUS ERYTHEMATOSUS Patient: DOB: Physician completing this form: Please complete the following questions regarding this patient's impairments and attach

More information